An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Abstract Background An increased relative eosinophil count (REC) has potential as a predictive biomarker for a beneficial clinical response and outcome to cancer immunotherapies. Therefore, the present study investigated the impact of an increased posttreatment REC on the prognosis of non‐small cell...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2024-01-01
Col·lecció:	Thoracic Cancer
Matèries:	dynamic biomarker immune checkpoint inhibitors increased eosinophil count non‐small cell lung cancer predictive factor
Accés en línia:	https://doi.org/10.1111/1759-7714.15191
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!